Results 331 to 340 of about 820,073 (407)
Vascular endothelial growth factor pathway's influence on bevacizumab efficacy in metastatic colorectal cancer treatment. [PDF]
Qin Y, Ma FY, Zhang Z, Zhao CH, Huang B.
europepmc +1 more source
Placental expression of estrogen and progesterone receptors and vascular endothelial growth factor in buffaloes suffering from uterine torsion. [PDF]
Amin YA+4 more
europepmc +1 more source
RETRACTION: Efficacy of Anti-Vascular Endothelial Growth Factor and Mitomycin C on Wound Gealing After Trabeculectomy in Glaucoma Patients: A Meta-Analysis. [PDF]
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Vascular Endothelial Growth Factor and Angiogenesis
Pharmacological Reviews, 2004Angiogenesis is a hallmark of wound healing, the menstrual cycle, cancer, and various ischemic and inflammatory diseases. A rich variety of pro- and antiangiogenic molecules have already been discovered. Vascular endothelial growth factor (VEGF) is an interesting inducer of angiogenesis and lymphangiogenesis, because it is a highly specific mitogen for
Allan T. van Oosterom+5 more
openaire +4 more sources
Vascular endothelial growth factor
Journal of Neuro-Oncology, 1997Vascular endothelial growth factor (VEGF) is a hypoxia-inducible angiogenesis and vascular permeability factor which is expressed in high amounts in perinecrotic palisading cells in human glioblastomas. In vitro VEGF gene expression is enhanced approximately ten times by hypoxia.
Plate, Karlheinz, Warnke, Peter C.
openaire +3 more sources
Vascular Endothelial Growth Factor
Ophthalmology, 2007Vascular endothelial growth factor (VEGF) signalling is a key stimulant of tumour neovascular growth, survival and capillary permeability, which are critical to solid tumour progression. The intracellular signalling responses that induce an angiogenic phenotype are dependent upon VEGF binding to specific transmembrane receptors on the endothelium and ...
Juliane M. Jürgensmeier+1 more
openaire +4 more sources